FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erin Joseph

Research Profile

Living Beings

Concepts & Ideas

Procedures

Anatomy

Chemicals & Drugs

Disorders

Breast Neoplasms

Co-author Network

Publications

TOP 3
Julie Eiseman; Jianxia Guo; Erin Joseph; Jing Lan; Ivana Vucenik
Pharmacokinetics and tissue distribution of inositol hexaphosphate in C.B17 SCID mice bearing human breast cancer xenografts.
William C Zamboni; Julie L Eiseman; Sandra Strychor; Patricia M Rice; Erin Joseph; Beth A Zamboni; Mark K Donnelly; Jennifer Shurer; Robert A Parise; Margaret E Tonda; Ning Y Yu; Per H Basse
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models.
Jianxia Guo; Robert A Parise; Erin Joseph; Merrill J Egorin; John Lazo; Edward V Prochownik; Julie L Eiseman
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erin Joseph (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Julie Eiseman; Jianxia Guo; Erin Joseph; Jing Lan; Ivana Vucenik
Pharmacokinetics and tissue distribution of inositol hexaphosphate in C.B17 SCID mice bearing human breast cancer xenografts.
Metabolism: clinical and experimental 2011;60(10):1465-74.
2011: William C Zamboni; Julie L Eiseman; Sandra Strychor; Patricia M Rice; Erin Joseph; Beth A Zamboni; Mark K Donnelly; Jennifer Shurer; Robert A Parise; Margaret E Tonda; Ning Y Yu; Per H Basse
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models.
Journal of liposome research 2011;21(1):70-80.
2009: Jianxia Guo; Robert A Parise; Erin Joseph; Merrill J Egorin; John Lazo; Edward V Prochownik; Julie L Eiseman
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice.
Cancer chemotherapy and pharmacology 2009;63(4):615-25.
2008: William C Zamboni; Laura L Jung; Sandra Strychor; Erin Joseph; Beth A Zamboni; Sarah A Fetterman; Brian J Sidone; Thomas G Burke; Dennis P Curran; Julie L Eiseman
Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice.
Investigational new drugs 2008;26(5):399-406.
2008: Jan H Beumer; Julie L Eiseman; Robert A Parise; Jeffry A Florian; Erin Joseph; David Z D'Argenio; Robert S Parker; Brittany Kay; Joseph M Covey; Merrill J Egorin
Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.
Cancer chemotherapy and pharmacology 2008;62(3):457-64.
2008: William C Zamboni; Sandra Strychor; Erin Joseph; Robert A Parise; Merrill J Egorin; Julie L Eiseman
Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
Cancer chemotherapy and pharmacology 2008;62(3):417-26.
2008: Jan H Beumer; Julie L Eiseman; Robert A Parise; Erin Joseph; Joseph M Covey; Merrill J Egorin
Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3529-35.
2007: William C Zamboni; Sandra Strychor; Erin Joseph; Dustin R Walsh; Beth A Zamboni; Robert A Parise; Margaret E Tonda; Ning Y Yu; Charles Engbers; Julie L Eiseman
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7217-23.
2007: Stephen Chad Kanick; Julie L Eiseman; Erin Joseph; Jianxia Guo; Robert S Parker
Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.
Journal of photochemistry and photobiology. B, Biology 2007;88(2-3):90-104.
2007: Jianxia Guo; Robert A Parise; Erin Joseph; Jing Lan; Su-Shu Pan; Beomjun Joo; Merrill J Egorin; Peter Wipf; John Lazo; Julie L Eiseman
Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284).
Anticancer research 2007;27(5A):3067-73.
2007: Robert A Parise; Merrill J Egorin; Julie L Eiseman; Erin Joseph; Joseph M Covey; Jan H Beumer
Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2007;21(13):1991-7.
2006: Jan H Beumer; Julie L Eiseman; Robert A Parise; Erin Joseph; Julianne L Holleran; Joseph M Covey; Merrill J Egorin
Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7483-91.
2006: Jan H Beumer; Erin Joseph; Merrill J Egorin; Robert S Parker; David Z D'Argenio; Joseph M Covey; Julie L Eiseman
A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5826-33.
2006: Jan H Beumer; Erin Joseph; Merrill J Egorin; Joseph M Covey; Julie L Eiseman
Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;831(1-2):147-55.
2005: Erin Joseph; Bruce Ganem; Julie L Eiseman; Donald J Creighton
Selective inhibition of MCF-7(piGST) breast tumors using glutathione transferase-derived 2-methylene-cycloalkenones.
Journal of medicinal chemistry 2005;48(21):6549-52.
2005: William C Zamboni; Laura L Jung; Merrill J Egorin; Deborah R Hamburger; Erin Joseph; Ruzhi Jin; Sandra Strychor; Ramesh K Ramanathan; Julie L Eiseman
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4867-74.
2005: Julianne L Holleran; Robert A Parise; Erin Joseph; Julie L Eiseman; Joseph M Covey; Elizabeth R Glaze; Aleksander V. Lyubimov; Ya-Fei Chen; David Z D'Argenio; Merrill J Egorin
Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3862-8.
2005: Zhe-Bin Zheng; Guozhang Zhu; Heekyung Tak; Erin Joseph; Julie L Eiseman; Donald J Creighton
N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
Bioconjugate chemistry 2005;16(3):598-607.
2005: John M Harrold; Julie L Eiseman; Erin Joseph; Sandra Strychor; William C Zamboni; Robert S Parker
Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts.
Journal of pharmacokinetics and pharmacodynamics 2005;32(1):65-83.
2005: Tushar S Garimella; Douglas Ross; Julie L Eiseman; J T Mondick; Erin Joseph; Takeo Nakanishi; S E Bates; Kenneth S. Bauer
Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors.
Cancer chemotherapy and pharmacology 2005;55(2):101-9.
2005: Julie L Eiseman; Jing Lan; Theodore F Lagattuta; Deborah R Hamburger; Erin Joseph; Joseph M Covey; Merrill J Egorin
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts.
Cancer chemotherapy and pharmacology 2005;55(1):21-32.
2004: Julie L Eiseman; Clive Brown-Proctor; Paul E Kinahan; Jerry M Collins; Lawrence W Anderson; Erin Joseph; Deborah R Hamburger; Su-Shu Pan; Chester A Mathis; Merrill J Egorin; Raymond W Klecker
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6669-76.
2004: William C Zamboni; Anne C Gervais; Merrill J Egorin; Jan H M Schellens; Eleanor G Zuhowski; Dick Pluim; Erin Joseph; Deborah R Hamburger; Peter Working; Gail T Colbern; Margaret E Tonda; Douglas M Potter; Julie L Eiseman
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Cancer chemotherapy and pharmacology 2004;53(4):329-36.
2003: Erin Joseph; Julie L Eiseman; Diana S Hamilton; Haibo Wang; Heekyung Tak; Zhebo Ding; Bruce Ganem; Donald J Creighton
Molecular basis of the antitumor activities of 2-crotonyloxymethyl-2-cycloalkenones.
Journal of medicinal chemistry 2003;46(1):194-6.
2002: William C Zamboni; Anne C Gervais; Merrill J Egorin; Jan H M Schellens; Deborah R Hamburger; Brian J Delauter; Amy Grim; Eleanor G Zuhowski; Erin Joseph; Dick Pluim; Douglas M Potter; Julie L Eiseman
Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2992-9.